Affluent Medical

company

About

Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€12M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Affluent Medical develops innovative new-generation mini-invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and risks of recurrence of the abdominal aortic aneurysm allowing patients to live more serenely facing an unpredictable risk of breakage; - Kalios and Epygon aim to provide more physiological surgical treatments for the repair or replacement of the mitral valve of the heart. Kalios can treat residual post-operative leakage and recurrent mitral insufficiency without having to reoperate patients. Epygon is today the only developing transcatheter valve to restore natural blood flow and safeguard the left ventricle. - Finally, Artus is the first electronically activatable artificial sphincter to treat stress urinary incontinence in men and women.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€12M
Affluent Medical has raised a total of €12M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2018 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2018 Debt Financing €12M 1 Kreos Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Affluent Medical is funded by 1 investors. Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Yes Debt Financing